About Cannara Biotech
Cannara Biotech is a publicly listed company based in Montreal (Canada) founded in 2018 by Zohar Krivorot. Medicinal cannabis cultivation facility. It operates in the Healthcare and Agriculture sectors. Cannara Biotech has raised $17.66 million across 5 funding rounds from investors including Canadian Imperial Bank of Commerce, FSD Pharma and Phoenician Capital. The company has 363 employees. Cannara Biotech has completed 1 acquisition, including Shop CBD. Its chief executive, as recorded, is Zohar Krivorot. Cannara Biotech offers products and services including Dried Flowers, Pre-Rolls, and Cannabis Oils. Its focus areas include HealthTech, Cannabis HealthTech, Cannabis Farming and Indoor Farming. Its legal entity is Cannara Biotech Inc. Its competitors include Canopy Growth, Organigram and C21 Investments.
Company details
Cannara Biotech was established in 2018 in Montreal, Canada, as a facility focused on the medicinal cannabis sector. Organic cannabis is cultivated and infused with medicinal herbs and flowers. Cannabis oil is also extracted through specialized processes. Operations are centered on production for medicinal applications, with the company serving the Canadian market from its primary location.
- Headquarters Montreal, Canada
- Employees 363
- Founders Zohar Krivorot
- Stage Public
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website cannara.ca
- Social LinkedIn Facebook Instagram
- Legal Name Cannara Biotech, Inc.
- Annual Revenue$56.82 M (USD)42.77as on Aug 31, 2024
- Net Profit$4.48 M (USD)-7.3as on Aug 31, 2024
- EBITDA-$8.03 M (USD)-160.19as on Aug 31, 2024
- Total Equity Funding$17.66M (USD)
in 5 rounds
- Latest Funding Round$4.61M (USD), Post-IPO
Feb 2026
- InvestorsCanadian Imperial Bank of Commerce
& 2 more
- Employee Count363
- Investments & Acquisitions
Products & Services of Cannara Biotech
Cannara Biotech offers a comprehensive portfolio of products and services, including Dried Flowers, Pre-Rolls, and Cannabis Oils.
Premium cultivated cannabis flowers for recreational and medical use.
Convenient pre-rolled cannabis for easy consumption.
Extracted oils from cannabis for versatile applications.
Funding Insights of Cannara Biotech
Cannara Biotech has successfully raised a total of $17.66M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.61 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.66M
- Total Rounds 5
- Last Round Post-IPO — $4.61M
- First Round $17.66M
(Jul 2018)
- Investors Count 3
All 5 funding rounds of Cannara Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $4.61M | Post-IPO | – | – | |
| Jul 2021 | $5M | Post-IPO | – | – | – |
| Oct 2019 | $6M | Debt – Conventional | – | – | |
| Jul 2019 | $2.16M | Post-IPO | – | – | – |
| Jul 2018 | $17.66M | Series A | – | FSD Pharma | – |
3 investors in total: 3 institutional.
Investors in Cannara Biotech
Cannara Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, FSD Pharma and Phoenician Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| phoeniciancapital.com | ||||
Commercial banking services are provided to individuals and businesses. | 1867 | cibc.com | Toronto, Canada | |
Cannabis company engaged in cultivation, processing, and manufacturing related activities | 2018 | fsdpharma.com | Cobourg, Canada |
Investor details for Cannara Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cannara Biotech
24 people are tracked at Cannara Biotech (15 in leadership, 9 in team); the tracked headcount is 363.
| Name | Role | Group |
|---|---|---|
Zohar Krivorot | Founder & CEO | Leadership |
Alex Wolfe | VP Business Development | Leadership |
Barry Laxer | Chief Operating Officer | Leadership |
Sean Wheeland | Director Of Packaging | Leadership |
Charles-Olivier Cardin | Director Of Cultivation | Leadership |
Bernardo Lobo | Creative Director | Leadership |
Joshua Besecker | Head Of Product | Leadership |
Vanessa Deschambault | Quality Assurance Director | Leadership |
Steven Allard | Cultivation Director/irrigation | Leadership |
Nicholas Sosiak | Chief Financial Officer | Leadership |
Auditeur Ca Noémi Follain Cpa | VP Finance And Accounting | Leadership |
Hari P. | Director Of Finance | Leadership |
Scott Carroll | Vice President, Commercial Strategy & Marketing | Leadership |
Tyler Shannon | Marketing Director | Leadership |
Katy Brown | Director Of Sales | Leadership |
Jesús Armando Castilla Moyado | Opérateur Machine Équipé De Préroulés A Cannara Biotech Inc | Team |
Sabrina Moutassaddak | Directrice De Production | Team |
Rafael Pungue | Accounts Payable Officer | Team |
Isabelle Paradis | Coordinatrice Logistique | Team |
Patricia Rogozynski | Production Coordinator | Team |
4 more people are available in the full profile.
Complete people profiles for Cannara Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cannara Biotech
Cannara Biotech is a publicly listed company on the TSXV with ticker symbol LOVE in Canada, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Apr 2021
- Listed onTSX-V: LOVE
- Listed entityCannara Biotech, Inc.
- Exchange sectorProcess industries
- ISINCA13765U2002
- Share price1.89 CAD (+6.18% on the day) · 2026-03-02
- Market capitalisation181,028,263.00 CAD
- Price to earnings14.8
- EPS (diluted, trailing year)0.13 CAD
- Volume (last session)63,183
- Analyst consensusStrong buy
Financials of Cannara Biotech
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | 81.8M CAD | 6.4M CAD | -11.6M CAD |
| 2023 | 57.3M CAD | 7.0M CAD | -4.4M CAD |
| 2022 | 35.8M CAD | 2.3M CAD | -2.4M CAD |
| 2021 | 17.0M CAD | -1.5M CAD | -2.9M CAD |
| 2020 | 2.5M CAD | -12.5M CAD | -9.0M CAD |
Detailed financial statements for Cannara Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cannara Biotech
Cannara Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Shop CBD.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Personal care products are retailed by Shop CBD in Canada. | shopcbd.com | Quebec, Canada | 2007 | May 2020 | •••• |
Complete acquisition details for Cannara Biotech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cannara Biotech
5 dated milestones of Cannara Biotech across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Cannara Biotech is founded.
- Funding First funding round of $17.7M.
- Acquisition Acquires Shop CBD.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $4.6M.
Competitors of Cannara Biotech
Cannara Biotech has 3 listed competitors in our database. They include Canopy Growth, Organigram and C21 Investments.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| canopygrowth.com | 2013 | Smiths Falls, Canada | 170 | Cannabis products are provided to support consumer wellness and health. | ||
| organigram.ca | 2013 | Moncton, Canada | Provider of cannabis products, brands, and international business development investments | |||
| cxxi.ca | 1987 | Vancouver, Canada | Cannabis and hemp-derived products are cultivated, processed, and supplied. |
Detailed competitors of Cannara Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cannara Biotech
The website of Cannara Biotech (cannara.ca) receives about 5.1K visits a month.
- Monthly visits5.1K
▼ 35.7% vs previous month
Websites whose visitors overlap most with Cannara Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| knighttx.com | 100% | 13.6K | #1,815,185 | View details |
Top companies in Cannabis Health Tech Ecosystem
2 companies that operate in the same segment as Cannara Biotech (Cannabis Health Tech Ecosystem) in Canada, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | USD 204.24 M | 960 | ||
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | USD 186.16 M | 898 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cannara Biotech
Complete news archive for Cannara Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cannara Biotech
Cannara Biotech was founded in 2018.
Cannara Biotech is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Zohar Krivorot is the CEO of Cannara Biotech, as recorded in our data. They have also founded this company.
Cannara Biotech is a funded company, having raised a total of $17.66M across 5 funding rounds to date. The company's 1st funding round was a Series A of $17.66M, raised on Jul 2018.
Cannara Biotech has 363 employees.
Annual revenue of Cannara Biotech is $56.82M as on Aug 31, 2024.
Cannara Biotech was established in 2018 in Montreal, Canada, as a facility focused on the medicinal cannabis sector. Organic cannabis is cultivated and infused with medicinal herbs and flowers. Cannabis oil is also extracted through specialized processes. Operations are centered on production for medicinal applications, with the company serving the Canadian market from its primary location.
Cannara Biotech's top competitors include Canopy Growth, Organigram and C21 Investments.
Cannara Biotech offers Dried Flowers, Pre-Rolls, and Cannabis Oils.
Yes, Cannara Biotech is publicly traded on TSXV under the ticker symbol LOVE.
Cannara Biotech has made 1 acquisition, including Shop CBD.
Cannara Biotech has 3 investors. Key investors include Canadian Imperial Bank of Commerce, FSD Pharma, and Phoenician Capital.